GT Biopharma annual meeting elects four directors, ratifies auditor

GT Biopharma, Inc.

Elected directors Michael Breen, Rajesh Shrotriya, Bruce Wendel, and Charles Casamento with majority for votes.
Ratified Weinberg & Company as independent auditor for 2023: 19,823,634 for, 849,463 against.
Advisory say-on-pay passed: 8,916,400 for, 2,034,860 against, 13,805 abstain, 9,736,535 broker non-votes.
Quorum of 55.2% represented at meeting (20,701,600 of 37,493,065 shares outstanding).

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

GT Biopharma, Inc. shareholders approved Non-binding advisory vote endorsing the Registrant's executive compensation at the 2023-06-28 meeting.

Proposal: say on pay
Outcome: passed
Meeting: 2023-06-28

Exact text from the filing

For Against Abstain Broker Non-Votes 8,916,400 2,034,860 13,805 9,736,535

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

GT Biopharma, Inc. shareholders approved Ratification of the appointment of Weinberg & Company, P.A. as the Registrant's independent accountants for the year ending December 31, 2023 at the 2023-06-28 meeting.

Proposal: auditor ratification
Outcome: passed
Meeting: 2023-06-28

Exact text from the filing

For Against Abstain 19,823,634 849,463 28,503

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

GT Biopharma, Inc. shareholders approved Election of four members of the Board of Directors at the 2023-06-28 meeting.

Proposal: director election
Outcome: passed
Meeting: 2023-06-28

Exact text from the filing

Director For Withheld Michael Breen 9,817,096 1,147,969 Rajesh Shrotriya, M.D. 9,728,749 1,236,316 Bruce Wendel 7,757,208 3,207,857 Charles J. Casamento 9,266,209 1,698,856

View on SEC.gov

546 shareholder votes filed in the last 30 days. Browse all shareholder votes →

GT Biopharma, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-23-023367

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.